Add
VRTX to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| VRTX > SEC Filings for VRTX > Form 8-K on 11-Jun-2009 | All Recent SEC Filings |
11-Jun-2009
Entry into a Material Definitive Agreement, Unregistered Sale of
On June 10, 2009, our subsidiary Vertex Pharmaceuticals (Europe) Limited entered into a lease with MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited for an additional 41,000 square feet in a facility adjacent to our current facility in Milton Park, Abingdon, England. The lease expires in 2024, with certain termination provisions in 2014 and 2019.
On June 5, 2009 and June 8, 2009, we entered into agreements with holders of our
4.75% Convertible Senior Subordinated Notes due 2013 pursuant to which the
holders agreed to exchange an aggregate of $143.5 million in aggregate principal
amount of those notes for an aggregate of 6.6 million shares of our common
stock, which is approximately 400,000 shares more than the number of shares into
which the notes were convertible under their original terms. The exchanges were
completed on June 10, 2009. The exchanges are exempt from registration under
Section 3(a)(9) of the Securities Act of 1933, as amended.
|
|